AG Campbell Advisory LLC Buys New Position in Mettler-Toledo International, Inc. $MTD

AG Campbell Advisory LLC acquired a new stake in shares of Mettler-Toledo International, Inc. (NYSE:MTDFree Report) in the fourth quarter, Holdings Channel.com reports. The fund acquired 1,030 shares of the medical instruments supplier’s stock, valued at approximately $1,436,000. Mettler-Toledo International comprises about 0.5% of AG Campbell Advisory LLC’s holdings, making the stock its 21st biggest holding.

A number of other institutional investors and hedge funds have also modified their holdings of the business. EverSource Wealth Advisors LLC boosted its stake in shares of Mettler-Toledo International by 2.4% during the 3rd quarter. EverSource Wealth Advisors LLC now owns 294 shares of the medical instruments supplier’s stock worth $361,000 after acquiring an additional 7 shares in the last quarter. Allworth Financial LP boosted its position in Mettler-Toledo International by 6.1% in the third quarter. Allworth Financial LP now owns 121 shares of the medical instruments supplier’s stock valued at $149,000 after buying an additional 7 shares in the last quarter. Evergreen Capital Management LLC increased its stake in shares of Mettler-Toledo International by 4.5% in the fourth quarter. Evergreen Capital Management LLC now owns 184 shares of the medical instruments supplier’s stock valued at $257,000 after buying an additional 8 shares in the last quarter. Meridian Wealth Management LLC raised its position in shares of Mettler-Toledo International by 1.7% during the fourth quarter. Meridian Wealth Management LLC now owns 488 shares of the medical instruments supplier’s stock worth $680,000 after acquiring an additional 8 shares during the last quarter. Finally, Verdence Capital Advisors LLC grew its holdings in Mettler-Toledo International by 2.0% during the 4th quarter. Verdence Capital Advisors LLC now owns 458 shares of the medical instruments supplier’s stock worth $639,000 after acquiring an additional 9 shares during the period. Hedge funds and other institutional investors own 95.07% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts have issued reports on MTD shares. JPMorgan Chase & Co. lowered their price target on Mettler-Toledo International from $1,413.00 to $1,200.00 and set a “neutral” rating for the company in a report on Monday, May 11th. Wolfe Research started coverage on Mettler-Toledo International in a research note on Tuesday, June 2nd. They set a “peer perform” rating for the company. Jefferies Financial Group raised shares of Mettler-Toledo International from a “hold” rating to a “buy” rating and lifted their price target for the company from $1,400.00 to $1,450.00 in a research note on Friday, March 20th. Barclays reduced their price objective on Mettler-Toledo International from $1,550.00 to $1,500.00 and set an “overweight” rating for the company in a research report on Tuesday, April 14th. Finally, Wall Street Zen downgraded Mettler-Toledo International from a “buy” rating to a “hold” rating in a report on Saturday, May 16th. Six equities research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the stock. According to MarketBeat.com, Mettler-Toledo International has an average rating of “Hold” and an average target price of $1,408.55.

Get Our Latest Research Report on MTD

Mettler-Toledo International Price Performance

Shares of NYSE:MTD opened at $1,145.08 on Friday. Mettler-Toledo International, Inc. has a 1 year low of $1,023.05 and a 1 year high of $1,525.17. The company has a market capitalization of $23.14 billion, a price-to-earnings ratio of 26.85, a P/E/G ratio of 2.39 and a beta of 1.27. The business’s 50-day moving average is $1,190.78 and its 200-day moving average is $1,301.85.

Mettler-Toledo International (NYSE:MTDGet Free Report) last issued its quarterly earnings data on Thursday, May 7th. The medical instruments supplier reported $8.91 EPS for the quarter, topping analysts’ consensus estimates of $8.70 by $0.21. The firm had revenue of $947.13 million during the quarter, compared to analyst estimates of $943.14 million. Mettler-Toledo International had a negative return on equity of 622.80% and a net margin of 21.40%.The company’s revenue for the quarter was up 7.2% on a year-over-year basis. During the same period in the previous year, the company posted $8.19 EPS. Mettler-Toledo International has set its FY 2026 guidance at 46.300-46.950 EPS and its Q2 2026 guidance at 10.700-10.850 EPS. Analysts anticipate that Mettler-Toledo International, Inc. will post 46.6 EPS for the current year.

Mettler-Toledo International Company Profile

(Free Report)

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.

Recommended Stories

Want to see what other hedge funds are holding MTD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mettler-Toledo International, Inc. (NYSE:MTDFree Report).

Institutional Ownership by Quarter for Mettler-Toledo International (NYSE:MTD)

Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.